Key Inclusion Criteria:~* Ability of the participant or his/her legally authorized representative to understand
the purpose and risks of the study and provide signed and dated informed consent and authorization to use
confidential health information in accordance with national and local participant privacy regulations.~* Must
have at least 6 years of education or work experience to exclude mental deficits other than MCI due to AD or
mild AD dementia.~* Must have evidence of cerebral AÎ² accumulation, based on a positive PET scan of the brain.
Previously obtained positron emission tomography (PET) scan (within 12 months of screening) is permissible.
Previous PET scan images must be submitted to the central imaging vendor to confirm that study inclusion
criteria are met.~* Must consent to apolipoprotein E (ApoE) genotyping.~* Must meet all of the following
clinical criteria for MCI due to AD or mild AD dementia according to NIA-AA criteria \[Albert 2011; McKhann
2011\], and must have the following: MCI due to AD (a CDR global score of 0.5, and an MMSE score between 24 and
30 (inclusive)), or Mild AD dementia (a CDR global score of 0.5 or 1, and as MMSE score between 20 and 26
(inclusive)).~Key
